Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Effect of Calcium β-hydroxy-β-methylbutyrate Supplementation in Sarcopenia in Liver Cirrhosis:A Randomized Double-blind Controlled Trial

Authors not listed

Shanghai Zhongshan Hospital · 2018

Abstract

This study is to evaluate the effect of CaHMB in the treatment of sarcopenia in liver cirrhosis.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Anonymous. (2018). The Effect of Calcium β-hydroxy-β-methylbutyrate Supplementation in Sarcopenia in Liver Cirrhosis:A Randomized Double-blind Controlled Trial. <em>Shanghai Zhongshan Hospital</em>. https://clinicaltrials.gov/study/NCT03605147
Vancouver
Anonymous. The Effect of Calcium β-hydroxy-β-methylbutyrate Supplementation in Sarcopenia in Liver Cirrhosis:A Randomized Double-blind Controlled Trial. Shanghai Zhongshan Hospital. 2018.
BibTeX
@misc{anon2018TheEff, title = {The Effect of Calcium β-hydroxy-β-methylbutyrate Supplementation in Sarcopenia in Liver Cirrhosis:A Randomized Double-blind Controlled Trial}, author = {Anonymous}, journal = {Shanghai Zhongshan Hospital}, year = {2018}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings